Catherine M. McDonald
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Catherine M. McDonald has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Sarah Gunnell Bellini
Nutrition, Dietetics, and Food Science Department Brigham Young University Provo Utah USA
3 shared publications - Dennis L. Eggett
Department of Statistics, Brigham Young University, Provo, UT 84602, USA
2 shared publications - Amanda Leonard
Department of Pediatric Nutrition, The Johns Hopkins Children's Center, Baltimore, USA
1 shared publication - Amelia McBride
Primary Children's Medical Center, 100 North Mario Capecchi Drive, Salt Lake City, UT 84113
1 shared publication - Anne Munck
CF Center, Hospital Necker Enfants Malades, 75743 Paris, France
1 shared publication - April Dean
Nutrition, Dietetics, and Food Science Department, Brigham Young University, Provo, UT 84602, USA; Freedom Prep Academy, 1190 W 900 N, Provo, UT 84604, USA
1 shared publication
Latest Publications
- 26 August 2026
- Published by Wiley in Nutrition in Clinical Practice
Parents'/Caregivers' perspectives on weight management in children with cystic fibrosis receiving modulator therapy: A cross‐sectional survey
Background: Modulator therapy in children with cystic fibrosis (cwCF) has improved lung function and digestive health, prompting changes in nutrition management strategies for many cwCF. The purpose of this study is to describe parents'/caregivers' perspectives on weight management in cwCF with the introduction of cystic fibrosis transmembrane conductance regulator modulator therapies (CFTRm). Methods: Researchers developed a cross‐sectional survey regarding parents'/caregivers' perceptions of weight management in cwCF. Content validity was established through four expert reviews and two cognitive interviews. A link to the survey was posted on two private Facebook pages with members who attended a CF clinic in the western United States and distributed to families attending a CF clinic in the southeastern United States. Survey responses were analyzed with descriptive statistics. Results: Forty‐nine parents/caregivers represented data for 60 cwCF. Sixty cwCF were prescribed CFTRm, and 46 (76.6%) had taken CFTRm for more than a year. Forty‐nine (86%) parents/caregivers agreed with clinicians on the weight classification of their cwCF. Many (52%) cwCF who received CFTRm for more than a year made changes to their diet. Parents/caregivers reported a mean score of 8.31 ± 2.47, with 10 being very comfortable talking with the clinic about their child's weight. Conclusion: Parents'/caregivers' perceptions of weight management in their cwCF varied. Nutrition strategy changes ranged from adding additional calories to decreasing calories and discontinuing supplemental nutrition after starting CFTRm. Individualized nutrition therapy is required in the era of CFTRm. Parents'/caregivers' concerns and perspectives about weight and diet are vital to assessing weight management.
- 26 August 2026
- Published by Wiley in Nutrition in Clinical Practice
Parents'/Caregivers' perspectives on weight management in children with cystic fibrosis receiving modulator therapy: A cross‐sectional survey
Background: Modulator therapy in children with cystic fibrosis (cwCF) has improved lung function and digestive health, prompting changes in nutrition management strategies for many cwCF. The purpose of this study is to describe parents'/caregivers' perspectives on weight management in cwCF with the introduction of cystic fibrosis transmembrane conductance regulator modulator therapies (CFTRm). Methods: Researchers developed a cross‐sectional survey regarding parents'/caregivers' perceptions of weight management in cwCF. Content validity was established through four expert reviews and two cognitive interviews. A link to the survey was posted on two private Facebook pages with members who attended a CF clinic in the western United States and distributed to families attending a CF clinic in the southeastern United States. Survey responses were analyzed with descriptive statistics. Results: Forty‐nine parents/caregivers represented data for 60 cwCF. Sixty cwCF were prescribed CFTRm, and 46 (76.6%) had taken CFTRm for more than a year. Forty‐nine (86%) parents/caregivers agreed with clinicians on the weight classification of their cwCF. Many (52%) cwCF who received CFTRm for more than a year made changes to their diet. Parents/caregivers reported a mean score of 8.31 ± 2.47, with 10 being very comfortable talking with the clinic about their child's weight. Conclusion: Parents'/caregivers' perceptions of weight management in their cwCF varied. Nutrition strategy changes ranged from adding additional calories to decreasing calories and discontinuing supplemental nutrition after starting CFTRm. Individualized nutrition therapy is required in the era of CFTRm. Parents'/caregivers' concerns and perspectives about weight and diet are vital to assessing weight management.
- Top Cited Papers
- 16 February 2026
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 25 (4) , 594-599
Consensus-based guidance for the nutritional management of children with cystic fibrosis on ELEXACAFTOR/TEZACAFTOR/IVACAFTOR
- 16 February 2026
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 25 (4) , 594-599
Top Cited PapersConsensus-based guidance for the nutritional management of children with cystic fibrosis on ELEXACAFTOR/TEZACAFTOR/IVACAFTOR
- 17 July 2024
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (3) , 507-515
Breastfeeding, growth, and lung disease in the first 3 years of life in children with cystic fibrosis
- 17 July 2024
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (3) , 507-515
Breastfeeding, growth, and lung disease in the first 3 years of life in children with cystic fibrosis
- 1 March 2024
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 39 (S1) , S57-S77
Cystic fibrosis and fat malabsorption: Pathophysiology of the cystic fibrosis gastrointestinal tract and the impact of highly effective CFTR modulator therapy
Cystic fibrosis (CF) is a progressive, genetic, multi‐organ disease affecting the respiratory, digestive, endocrine, and reproductive systems. CF can affect any aspect of the gastrointestinal (GI) tract, including the esophagus, stomach, small intestine, colon, pancreas, liver, and gall bladder. GI pathophysiology associated with CF results from CF membrane conductance regulator (CFTR) dysfunction. The majority of people with CF (pwCF) experience exocrine pancreatic insufficiency resulting in malabsorption of nutrients and malnutrition. Additionally, other factors can cause or worsen fat malabsorption, including the potential for short gut syndrome with a history of meconium ileus, hepatobiliary diseases, and disrupted intraluminal factors, such as inadequate bile salts, abnormal pH, intestinal microbiome changes, and small intestinal bacterial overgrowth. Signs and symptoms associated with fat malabsorption, such as abdominal pain, bloating, malodorous flatus, gastroesophageal reflux, nausea, anorexia, steatorrhea, constipation, and distal intestinal obstruction syndrome, are seen in pwCF despite the use of pancreatic enzyme replacement therapy. Given the association of poor nutrition status with lung function decline and increased mortality, aggressive nutrition support is essential in CF care to optimize growth in children and to achieve and maintain a healthy body mass index in adults. The introduction of highly effective CFTR modulator therapy and other advances in CF care have profoundly changed the course of CF management. However, GI symptoms in some pwCF may persist. The use of current knowledge of the pathophysiology of the CF GI tract as well as appropriate, individualized management of GI symptoms continue to be integral components of care for pwCF.
- 1 March 2024
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 39 (S1) , S57-S77
Cystic fibrosis and fat malabsorption: Pathophysiology of the cystic fibrosis gastrointestinal tract and the impact of highly effective CFTR modulator therapy
Cystic fibrosis (CF) is a progressive, genetic, multi‐organ disease affecting the respiratory, digestive, endocrine, and reproductive systems. CF can affect any aspect of the gastrointestinal (GI) tract, including the esophagus, stomach, small intestine, colon, pancreas, liver, and gall bladder. GI pathophysiology associated with CF results from CF membrane conductance regulator (CFTR) dysfunction. The majority of people with CF (pwCF) experience exocrine pancreatic insufficiency resulting in malabsorption of nutrients and malnutrition. Additionally, other factors can cause or worsen fat malabsorption, including the potential for short gut syndrome with a history of meconium ileus, hepatobiliary diseases, and disrupted intraluminal factors, such as inadequate bile salts, abnormal pH, intestinal microbiome changes, and small intestinal bacterial overgrowth. Signs and symptoms associated with fat malabsorption, such as abdominal pain, bloating, malodorous flatus, gastroesophageal reflux, nausea, anorexia, steatorrhea, constipation, and distal intestinal obstruction syndrome, are seen in pwCF despite the use of pancreatic enzyme replacement therapy. Given the association of poor nutrition status with lung function decline and increased mortality, aggressive nutrition support is essential in CF care to optimize growth in children and to achieve and maintain a healthy body mass index in adults. The introduction of highly effective CFTR modulator therapy and other advances in CF care have profoundly changed the course of CF management. However, GI symptoms in some pwCF may persist. The use of current knowledge of the pathophysiology of the CF GI tract as well as appropriate, individualized management of GI symptoms continue to be integral components of care for pwCF.
- 4 November 2023
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 23 (3) , 532-537
Developing a nutrition screening tool for children with cystic fibrosis ages 0 to 2 years
- 4 November 2023
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 23 (3) , 532-537
Developing a nutrition screening tool for children with cystic fibrosis ages 0 to 2 years
- 1 April 2021
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 42, 206-211
Changes in handgrip strength in children with cystic fibrosis compared to children without cystic fibrosis
- 1 April 2021
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 42, 206-211
Changes in handgrip strength in children with cystic fibrosis compared to children without cystic fibrosis
- 1 May 2016
- Published by Elsevier in Journal of the Academy of Nutrition and Dietetics
- Vol. 116 (5) , 771-773
Nutrition Screening and Diagnosis with Early, Appropriate Interventions Are Critical Components of Cystic Fibrosis Management
- 1 May 2016
- Published by Elsevier in Journal of the Academy of Nutrition and Dietetics
- Vol. 116 (5) , 771-773
Nutrition Screening and Diagnosis with Early, Appropriate Interventions Are Critical Components of Cystic Fibrosis Management
- 26 December 2012
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 12 (5) , 538-543
Self-efficacy: Empowering parents of children with cystic fibrosis
- 26 December 2012
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 12 (5) , 538-543
Self-efficacy: Empowering parents of children with cystic fibrosis
- 1 July 2010
- Published by Elsevier in Journal of Nutrition Education and Behavior
- Vol. 42 (4) , S119
Assessing the Lifestyle Habits of Overweight/Obese Youth Identifies Intervention Target Areas for Weight Management Programs
- 1 July 2010
- Published by Elsevier in Journal of Nutrition Education and Behavior
- Vol. 42 (4) , S119
Assessing the Lifestyle Habits of Overweight/Obese Youth Identifies Intervention Target Areas for Weight Management Programs
- Open Access
- 8 December 2009
- Published by SAGE Publications in ICAN: Infant, Child, & Adolescent Nutrition
- Vol. 1 (6) , 325-331
Nutrition Knowledge and Confidence Levels of Parents of Children With Cystic Fibrosis
Optimal growth and nutrition status predict better lung function and longevity for children with cystic fibrosis (CF). Daily nutrition therapy for children with CF requires adequate food resources, parental knowledge of nutrition and behavior management, and confidence in one’s ability to apply the skills. The Mountain West Cystic Fibrosis Consortium Questionnaire (MWCFC-Q) was designed to identify educational intervention targets to improve the growth and nutrition of children with CF. Parents of children with CF returned 305 anonymous MWCFC-Qs. Data analyzed included household food security, knowledge of nutrition and general CF therapies, and self-confidence in one’s ability to manage components of CF care. Factors associated with food insecurity were reported by 26.3% of respondents. The median accuracy for questions regarding nutrient content of commonly used foods was 71.4% and 57.9% for CF nutrition therapy. Parents’ self-confidence in overall CF management was relatively high at a mean value 8.28 ± 1.22 of 10 possible. However, mean self-confidence in the CF nutrition domain was significantly less than mean self-confidence for the CF-related tasks domain, which included chest physiotherapy and medication administration (7.75 ± 1.56, 8.62 ± 1.24, P < .001, respectively). Parental knowledge of nutrition for CF and confidence in the application of this knowledge can improve the growth and nutrition status of children with CF. Identification of food security issues may enable health care professionals to adjust nutrition interventions and direct families to appropriate food resources. The MWCFC-Q could be useful for designing and testing educational interventions for nutrition management of CF.
- 8 December 2009
- Published by SAGE Publications in ICAN: Infant, Child, & Adolescent Nutrition
- Vol. 1 (6) , 325-331
Open AccessNutrition Knowledge and Confidence Levels of Parents of Children With Cystic Fibrosis
Optimal growth and nutrition status predict better lung function and longevity for children with cystic fibrosis (CF). Daily nutrition therapy for children with CF requires adequate food resources, parental knowledge of nutrition and behavior management, and confidence in one’s ability to apply the skills. The Mountain West Cystic Fibrosis Consortium Questionnaire (MWCFC-Q) was designed to identify educational intervention targets to improve the growth and nutrition of children with CF. Parents of children with CF returned 305 anonymous MWCFC-Qs. Data analyzed included household food security, knowledge of nutrition and general CF therapies, and self-confidence in one’s ability to manage components of CF care. Factors associated with food insecurity were reported by 26.3% of respondents. The median accuracy for questions regarding nutrient content of commonly used foods was 71.4% and 57.9% for CF nutrition therapy. Parents’ self-confidence in overall CF management was relatively high at a mean value 8.28 ± 1.22 of 10 possible. However, mean self-confidence in the CF nutrition domain was significantly less than mean self-confidence for the CF-related tasks domain, which included chest physiotherapy and medication administration (7.75 ± 1.56, 8.62 ± 1.24, P < .001, respectively). Parental knowledge of nutrition for CF and confidence in the application of this knowledge can improve the growth and nutrition status of children with CF. Identification of food security issues may enable health care professionals to adjust nutrition interventions and direct families to appropriate food resources. The MWCFC-Q could be useful for designing and testing educational interventions for nutrition management of CF.